Skip to main content
NewslettersWatchlist

Aptose Bioscns(APTO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Aptose Bioscns

251 CONSUMERS ROAD SUITE 1105
TORONTO A6 M2J 4R3 CAN
P: 64-7479-9828
http://www.aptose.com

Profile

Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.

Key Executives

NameTitle
William G. RiceCEO/Chairman of the Board/Director/President
Fletcher PayneCFO/Chief Accounting Officer/Other Executive Officer/Senior VP
Rafael BejarChief Medical Officer/Senior VP

More from The Globe

How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy
Former President Donald Trump sits in Manhattan Criminal Court in New York, Thursday, April 25.
Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders
Dye & Durham Ltd. says it has launched a strategic review of its non-core assets in an effort to reduce its debt. The logo for Dye & Durham Ltd. is shown in this undated handout photo. THE CANADIAN PRESS/HO
The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market
Traders work on the floor of the New York Stock Exchange shortly after the opening bell, Wednesday, April 24.
Fiera Capital’s largest shareholder looks to sell stake in company
Jean-Guy Desjardins, global CEO and founder of Fire Capital posses for a portrait at Fiera Capital, in Montreal on Monday, January 8, 2024. Evan Buhler/The Globe and Mail�
The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.
The close: Stocks higher as investors digest earnings
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., March 20, 2024.
The close: Stocks higher with major corporate earnings on tap
A trader works on the trading floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 5.
the rob interview
Head in the cloud: How Cisco CEO Chuck Robbins is reviving a Silicon Valley icon
Cisco CEO Chuck Robbins, seen in Toronto on Oct. 12, is a 6-foot-4 former college basketball player and 20-year veteran of the company. He steps into what no one would describe as a dream job: a lengthy slog to direct a one-time Silicon Valley star through its challenging next chapter.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.